Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jeyachchandran Visvalingam has a total of 47 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Multidimensional Wound Healing Outcomes in Chronic and Complex Wounds: A Real‐World Case Series With a Thermoreversible Wound Gel

    by Iris Noland, Miloslav Sailer, Jeyachchandran Visvalingam, Rohan Pointer, Robert B. Huizinga

    Chronic and complex wounds frequently exhibit delayed healing associated with persistent inflammation, microbial burden and biofilm formation. This prospective observational case series describes wound‐healing outcomes associated with adjunctive use of a thermo‐reversible antimicrobial wound gel (TRG) in 17 adult patients with chronic wounds treated in an outpatient setting. A total of 28 wounds were analysed over up to 12 weeks using clinically relevant endpoints including percentage area reduction (PAR), wound bed tissue composition, exudate level, tissue oxygenation and patient‐reported pain. Mean PAR was 43.9% at the wound level and 42.7% at the patient level. The proportion of wounds demonstrating epithelial tissue increased from 25.0% to 68.8%, while necrotic tissue decreased from 25.0% to 12.5%. Low exudate increased from 41.2% at baseline to 64.7% at final assessment. Mean pain scores decreased from 4.76 to 2.18 ( p = 0.0125). In patients with available tissue oxygenation data, change in oxygenation was positively correlated with PAR ( p = 0.011). These findings suggest that adjunctive use of the TRG was associated with improvement across multiple clinical outcomes in a real‐world population of patients with chronic and complex wounds and support further evaluation in controlled studies.

  • Open Access

    Efficacy of a novel thermo-reversible wound gel against antibiotic tolerant biofilm

    by Jeyachchandran Visvalingam, Anna Muzaleva, Miloslav Sailer, Sarvesh Logsetty, Robert B. Huizinga

    Chronic wounds are frequently colonized by biofilm-forming bacteria, and one of the defining characteristics of these infections is the resulting tolerance to antibiotics. A novel thermo-reversible antimicrobial wound gel (revyve ® Antimicrobial Wound Gel, TRG), formulated to target biofilms, was evaluated for its ability to inactivate antibiotic-tolerant biofilms using both a colony biofilm model and a porcine skin explant biofilm model. Mature biofilms of Staphylococcus aureus and Pseudomonas aeruginosa were grown on nitrocellulose membranes or porcine skin explants for 72 hours at 37 °C. Before any treatment, viable numbers of S. aureus and P. aeruginosa were ≥ 9.7 log CFU in the colony biofilm model, and 8.3 and 6.6 log CFU, respectively, in the porcine skin explant model. Biofilms were then washed and treated with defined concentrations of antibiotics for 24 hours to select for antibiotic-tolerant cells, followed by up to 7 days of TRG treatment. Antibiotic treatment caused a significant (P ≤ 0.05) reduction in viable numbers of both organisms in both models, resulting in survival of ≥ 5 log CFU of tolerant biofilm cells. Subsequent treatment with TRG reduced viable numbers of S. aureus to below detection limits, causing a 7.9 log CFU reduction at 24 hours in the colony biofilm model and a 5.5 log CFU reduction at 72 hours in the porcine skin explant model. In the colony biofilm model, viable numbers of P. aeruginosa were reduced to below the detection limit, corresponding to a 6.1 log CFU reduction at 24 hours, while in the porcine skin explant model, TRG caused a 3.5 log CFU reduction at 72 hours, with no further changes observed up to 7 days. These results indicate that TRG was effective at inactivating antibiotic-tolerant biofilms and may serve as a valuable tool in combating biofilms in chronic wounds.


  • Open Access

    Wound Healing Property of a Novel Thermo‐Reversible Wound Gel With Lasting Antimicrobial and Antibiofilm Activity

    by Jeyachchandran Visvalingam, Jie Li, Ivan Jozic, Sheung Pui Lee, Miloslav Sailer, Joel Gil, Michael Solis, Stephen C. Davis, Robert B. Huizinga

    This study investigated the efficacy and safety of a novel thermo‐reversible antimicrobial wound gel (TRG, revyve Antimicrobial Wound Gel) designed to combat biofilm‐related infections in wounds. The TRG was evaluated for its ability to disrupt biofilms, sustain antimicrobial activity and promote wound healing. The gel exhibited thermo‐reversible properties, transitioning from a less viscous liquid ≤ 18°C to a highly viscous solid gel at wound temperature which would facilitate easy application and removal. Antimicrobial testing demonstrated that TRG effectively inactivated a broad range of wound‐related pathogens, including Staphylococcus aureus and Pseudomonas aeruginosa , with a 99.99%–99.9999% reduction in bacterial counts within 30 min. The TRG also maintained its antimicrobial efficacy after multiple inoculations with high microbial load (10 7 CFU/mL) over 7 days. In vitro biofilm assays showed effectiveness against biofilm bacteria with a reduction of ≥ 99.99% bacterial counts with one application over the course of 7 days. Biocompatibility testing confirmed that TRG was safe, with no signs of tissue necrosis or signs of tissue damage and no impact on wound healing in a porcine wound model. TRG's ability to reduce both planktonic and biofilm‐based bacteria without compromising wound healing makes it a promising candidate for treating both chronic and acute wounds.


  • Open Access

    Wound Gel Formulations Containing Poloxamer 407 and Polyhexanide Have In Vitro Antimicrobial and Antibiofilm Activity Against Wound-Associated Microbial Pathogens

    by Jeyachchandran Visvalingam, Nandadeva Yakandawala, Suresh Regmi, Adetola Adeniji, Parveen Sharma, Miloslav Sailer

    Chronic wounds are often caused or exacerbated by microbial biofilms that are highly resistant to antimicrobial treatments and that prevent healing. This study compared the antimicrobial and antibiofilm activity of nine topical wound treatments, comprising gels with different concentrations of poloxamer 407 (20–26%) and different pH levels (4–6) and containing polyhexanide (PHMB) as an antimicrobial agent; the effects of pH on wound gels containing this agent have not been previously reported. The wound gel formulations were tested against six common wound-associated microbial pathogens: Staphylococcus aureus, S. epidermidis, Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii, and Candida albicans. Time-kill assays were used to assess antimicrobial activity against planktonic forms of each species, and a colony biofilm model was used to assess antibiofilm activity against existing biofilms as well as inhibition of new biofilm formation. Biofilm inhibition activity was also assessed in the presence of common wound dressing materials. Wound gels with higher pH levels exhibited stronger antimicrobial activity, while poloxamer 407 concentrations >20% negatively impacted antimicrobial activity. Wound gel formulations were identified that had antimicrobial, antibiofilm, and biofilm inhibition activity against all tested species in vitro. Biofilm inhibition activity was not affected by contact with common wound dressings. Further development of these wound gels may provide a valuable new option for the treatment and prevention of chronic wounds.


  • Transcriptome Analysis of Listeria monocytogenes Exposed to Beef Fat Reveals Antimicrobial and Pathogenicity Attenuation Mechanisms

    by Yuan Yao Chen, Arun Kommadath, Payam Vahmani, Jeyachchandran Visvalingam, Michael E. R. Dugan, Xianqin Yang

    Listeria monocytogenes is a deadly intracellular pathogen mostly associated with consumption of ready-to-eat foods. This study investigated the effectiveness of total beef fat (BF-T) from flaxseed fed cattle, and its fractions enriched with monounsaturated fatty acids (BF-MUFA) and polyunsaturated fatty acids (BF-PUFA) along with commercially available long chain fatty acids (LC-FA) as natural antimicrobials against L. monocytogenes. BF-T was ineffective at concentrations up to 6 mg/ml, while L. monocytogenes was susceptible to BF-MUFA and BF-PUFA with the minimum inhibitory concentrations (MICs) at pH 7 being 0.33 ± 0.21 mg/ml and 0.06 ± 0.03 mg/ml, respectively. The MIC of C14:0 was significantly lower than those of C16:0 and C18:0 (P < 0.05). c9-C16:1, C18:2n-6 and C18:3n-3, showed stronger inhibitory activity than c9-C18:1 and conjugated C18:2, with MICs < 1 mg/ml. Furthermore, global transcriptional analysis by RNA-seq was performed to characterize the response of L. monocytogenes to selected FA. Function analysis indicated that antimicrobial LC-UFA repressed the expression of genes associated with nutrient transmembrane transport, energy generation, and oxidative stress resistance. On the other hand, upregulation of ribosome assembly and translation process is possibly associated with adaptive and repair mechanisms in response to LC-UFA. Virulence genes and genes involved in bile, acid and osmotic stress were largely downregulated, more so for c9-C16:1, C18:2n-6 and C18:3n-3, likely through interaction the master virulence regulator PrfA and the alternative Sigma factor σB. ImportanceListeria monocytogenes is a bacterial pathogen known for its ability to survive and thrive under adverse environments and as such its control poses a significant challenge, especially with the trend of minimally processed and ready-to-eat foods. This work investigated the effectiveness of fatty acids from various sources as natural antimicrobials against L. monocytogenes, and evaluated their potential role in L. monocytogenes pathogenicity modulation, using the strain ATCC 19111. The findings show LC-UFA including unsaturated beef fat fractions from flaxseed fed cattle could have the potential to be used as effective antimicrobials for L. monocytogenes, through controlling growth as well as virulence attenuation. This not only advances our understanding on the mode of action of LC-UFA against L. monocytogenes, but also suggests the potential use of beef fat or its fractions as natural antimicrobials for controlling foodborne pathogens.


  • Facultative Anaerobes Shape Multispecies Biofilms Composed of Meat Processing Surface Bacteria and Escherichia coli O157:H7 or Salmonella enterica Serovar Typhimurium

    by Jeyachchandran Visvalingam, Hui Wang, Tim C. Ells, Xianqin Yang

    Results of this study demonstrate that Salmonella enterica serovar Typhimurium and E. coli O157:H7 can integrate into biofilms when cocultured with bacteria from meat plant processing surfaces. However, the degree of biofilm formation for both pathogens was substantially reduced in the presence of the competing microbiota, with S. Typhimurium more greatly affected than E. coli O157:H7. The expression of extracellular determinants such as curli and cellulose appears to be less important for biofilm formation of the pathogens in multispecies cultures than in monoculture. In contrast to previous reports regarding food processing surface bacteria, data collected here also demonstrate that facultative anaerobes may have a competitive edge over strict aerobes in establishing multispecies biofilms. It would be important to take into account the presence of background bacteria when evaluating the potential persistence of a pathogen in food processing facilities.


  • Dynamics of Biofilm Formation by Salmonella Typhimurium and Beef Processing Plant Bacteria in Mono- and Dual-Species Cultures

    by Jeyachchandran Visvalingam, Peipei Zhang, Timothy C. Ells, Xianqin Yang

    This study aimed to determine the impact of bacteria from a beef plant conveyor belt on the biofilm formation of Salmonella in dual-species cultures. Beef plant isolates (50) including 18 Gram-negative aerobes (GNA), 8 Gram-positive aerobes (GPA), 5 lactic acid bacteria (LAB), 9 Enterobacteriaceae (EB), and 10 generic Escherichia coli (GEC) were included for developing biofilms in mono- and co-culture with S. Typhimurium at 15 °C for 6 days. Five selected cultures in planktonic form and in biofilms were tested for susceptibility to two commonly used sanitizers (i.e. E-San and Perox-E Plus). In mono-cultures, ≥ 80, 67, 61, 20, and 13% of GEC, EB, GNA, LAB, and GPA, respectively, developed measurable biofilms after 2 days, while all co-culture pairings with S. Typhimurium achieved some level of biofilm production. The predominant effect of EB and only effect of GEC strains on the biofilm formation of S. Typhimurium was antagonistic, while that of Gram-positive bacteria was synergistic, with the effect being more prominent on day 6. The effect was highly variable for the GNA isolates. Six aerobic isolates that formed moderate/strong biofilms by day 2 greatly boosted the co-culture biofilm formation. Seven Gram-negative bacteria were antagonistic against the biofilm formation of the co-cultures. Both sanitizers completely inactivated the selected planktonic cultures, but were largely ineffective against biofilms. In conclusion, all beef plant isolates assessed formed biofilms when paired with S. Typhimurium. Aerobic biofilm formers may create a more favorable condition for Salmonella biofilm formation, while some beef plant isolates have potential as a biocontrol strategy for Salmonella biofilms.


  • Impact of persistent and nonpersistent genericEscherichia coliandSalmonellasp. recovered from a beef packing plant on biofilm formation byE. coliO157

    by J. Visvalingam, T.C. Ells, X. Yang

    Aims To examine the influence of meat plant Escherichia coli and Salmonella sp. isolates on E. coli O157 biofilm formation. Methods and Results Biofilm formation was quantified by crystal violet staining (A570 nm) and viable cell numbers for up to 6 days at 15°C. All five persistent E. coli genotypes formed strong biofilms when cultured alone or co‐cultured with E. coli O157, with A570 nm values reaching ≥4·8 at day 4, while only two of five nonpersistent genotypes formed such biofilms. For E. coli O157:H7 co‐culture biofilms with E. coli genotypes 136 and 533, its numbers were ≥1·5 and ≥1 log CFU per peg lower than those observed for its mono‐culture biofilm at days 2 and 4, respectively. The number of E. coli O157:NM in similar co‐culture biofilms was 1 log CFU per peg lower than in its mono‐culture biofilm at day 4 and 6, respectively. Salmonella sp. lowered the number of E. coli O157:NM by 0·5 log unit, once, at day 6. Conclusion Generic E. coli may outcompete E. coli O157 strains while establishing biofilms. Significance and Impact of the study Findings advance knowledge regarding inter‐strain competition for a similar ecological niche and may aid development of biocontrol strategies for E. coli O157 in food processing environments.